Investors
Announcements 2017
AGM Notice Announcement
Board Meeting Notice July 27, 2017
Glenmark Pharmaceuticals Receives Tentative ANDA Approval For Solifenacin Succinate Tablets, 5 mg and 10 mg
Glenmark's consolidated revenue increased by 6.52% to Rs. 24,571.83 Mn for Q4 FY 2016 -- 17
Q4 FY 2017 Results sheet & Statement of Assets and Liabilities
Q4 FY 2017 Management Discussions and Analysis
The Free Press Journal
Intimation regarding NSE board meeting
Statement on Form 483 at the Ankleshwar API plant
Glenmark’s Q3 FY 17 results
Glenmark’s MDA Q3 FY 17
Glenmark’s consolidated revenue increases by 42.55 % to Rs. 25,350.08 Mn for Q3 FY 2016 – 17
J P Morgan Healthcare Conference – presentation
Intimation regarding board meeting
About Us
Leading, integrated, global, research-led organization. Words which define us and our vision to discover a healthier future